# paper_9ec8c4761c4f171b — 特定V2方案

## paper_id

paper_9ec8c4761c4f171b

## batch

2

## created_at

2026-09-28T16:52:40.546751+00:00

## source_documents

[
  {
    "role": "main",
    "path": "papers/paper_9ec8c4761c4f171b/documents/main.pdf",
    "sha256": "49d8e9997164eb5f8400e8730c64d2fc6b5929e6e5c9ba431ba766c4486c51be",
    "material_type": "primary_article",
    "pdf_pages_1_based": [
      4,
      5,
      6,
      7,
      8,
      14
    ],
    "sections_figures_tables": "PDF p4 Scheme3 identities; p5 molecular-form evidence and Scheme4; pp5–7 optical discussion/computational methods; p8 Table2 measured absorption maxima. PDF p14 compound7a characterization lists 1H NMR (500 MHz,DMSO-d6),14.07ppm."
  },
  {
    "role": "si",
    "path": "papers/paper_9ec8c4761c4f171b/documents/supplementary_001.pdf",
    "sha256": "29b1c6d10ffb42a053b3303aad720cad5fd49a336015dd6b2fd76a1a98ba742a",
    "material_type": "actual_supporting_information",
    "pdf_pages_1_based": [
      70,
      71,
      72,
      73,
      74,
      82,
      83,
      84,
      85,
      86,
      87,
      88,
      154,
      155,
      156,
      157
    ],
    "sections_figures_tables": "PDF pp70–74 optical/computational tables and alternative-form spectra; pp82–88 gas/chloroform structures; pp154–157 7a spectra. Visually read p155 spectrum: peak14.07ppm, SOLVENT CDCl3, TE296.4K, SFO1 500.1340010MHz; this conflicts with main p14 solvent label."
  }
]

## source_scope

The source investigates pyrazolone molecular forms and optical substitution/solvent response. This subset keeps the chemically comparable N-phenyl7a,8a,5g identities and cross-spectroscopic interpretation, without introducing a new biological question.

## old_task_diagnosis

{
  "task_and_public_matrix": "7a/8a及5g/7a正确匹配，四种7a候选移动质子映射，吸收与NMR/IR联合判别；允许物种坍缩与对应峰不存在。",
  "contract_panels": [
    "matched_absorption",
    "species_crosscheck",
    "solvent_species_attribution"
  ],
  "fixed_hypothesis_count": "hypotheses.minItems=2 in V1; removed in V2",
  "private_rules": "V1 same mandatory panels were bound into scientific rules; supersede rather than conceal them.",
  "source_issues": [
    "Remove fixed four-tautomer candidate list, mandatory shielding/IR matrix, preselected matched-pair effect panels and population-decomposition algorithm.",
    "Remove Z-HK winner labels/stereo from public graphs and author NMR/IR functional assignments from observation keys.",
    "Do not substitute the old6a NH-pyrazolone reference for these N-phenyl identities."
  ]
}

## proposed_ar_problem

Explain the absorption behaviour of pyrazolones 7a, 8a and 5g in chloroform and DMF, and assess what the available independent spectroscopic observations establish about the molecular forms underlying that behaviour. Determine how securely a molecular explanation follows from the combined evidence.

## agent_decisions

[
  "Decide which molecular forms and environmental models are relevant to the supplied observations.",
  "Choose how to distinguish structural or environmental explanations using the available optical and independent spectroscopic information.",
  "Choose how much evidence is sufficient for a species assignment or an unresolved alternative."
]

## public_input_changes

[
  "Keep three source identities with full graphs/formulas and neutral singlet identity states.",
  "Keep measured absorption maxima and contextual NMR/IR features with media; no computed source spectrum becomes public.",
  "Document that a drawing is not a selected solution species; agents define needed derived models and mappings.",
  "Correct the former exclusive CDCl3 attribution of 7a14.07ppm to two conflicting source annotations; no final solvent is assigned and no claim of a replicated two-solvent measurement is made."
]

## submission_and_scoring

{
  "evidence_required": "Provide quantitative evidence for the observed solvent/structure-dependent absorption and for any molecular-form interpretation you assert. Retain raw calculations or original data and analysis linking measurements to models. Identify corresponding atoms, modes or electronic transitions when those assignments enter your argument. Explain joint consistency or conflict with the independent spectroscopic facts; merely reproducing an optical maximum cannot establish a unique form. If forms converge to the same physical endpoint, document that observation rather than inventing distinct minima. If using this resonance, retain both source annotations and assess the consequence of unresolved medium attribution. A bounded interpretation or omitting it from solvent-specific quantitative calibration is valid when justified. Resolving the publication discrepancy is not a mandatory new calculation or an agent input failure.",
  "scientific_criteria": [
    "Verify N-phenyl7a/8a/5g identities and conservation of composition, proton/electron balance and atom correspondence for derived models. Do not use the NH analogue6a or another substituent as the same compound. Keep the measurement media distinct. The 7a14.07ppm solvent field is unresolved, not a fixed CDCl3 or DMSO-d6 identity constraint.",
    "Evaluate auditable optical quantities and any independent spectroscopic/state evidence actually used. Appropriate state/mode/shift references and raw artifacts must support numerical comparisons; a KS orbital gap cannot silently stand in for an absorption maximum. Any use of 7a14.07ppm must cite its main/SI solvent-label discrepancy; it is not an unambiguous medium-specific reference or two independent measurements.",
    "Assess whether a molecular explanation accounts for the observed compound/solvent behaviour and respects the independent NMR/IR constraints. Species redistribution, fixed-form effects or another in-scope explanation is acceptable only as far as its evidence supports it; no named tautomer or mandatory decomposition is privileged. Do not infer solvent-invariant NMR behaviour from the duplicated14.07ppm annotation.",
    "Assess molecular-model, medium and measurement limitations relevant to the asserted distinction. Source-series ranges cannot become precise per-species target values. Population claims require a defensible common thermodynamic basis and justified scope, not an assumed equilibrium from arbitrary SCF energies. Treat the main p14 DMSO-d6 versus SI p155 CDCl3 disagreement for7a14.07ppm as unresolved source provenance. Credit justified bounded use or exclusion from solvent-specific calibration; do not require a particular extra calculation or penalize the agent for the publication conflict.",
    "State what explains the measured behaviour and which molecular-form conclusions are or are not established for the three identities and environments. A bounded support set or nonidentifiability is acceptable with evidence, while unperformed core reasoning cannot be relabeled uncertainty. If7a14.07ppm contributes to a conclusion, state the unresolved solvent provenance and its consequence."
  ],
  "contract": "Structured methods, chosen models, executions, numerical measurements, evidence hashes, findings, concise decision records and limitations; self-defined ideas with no minimum count; complete/partial/failed/blocked distinguished. No fixed panel.",
  "runtime": "dual_axis_100.open_research.v1; common result criteria; AR independent research and PR disclosed-source reproduction process differ. Semantic calibration remains pending."
}

## pr_alignment

The authors favour a Z hydrazone-keto description from XRD, NMR/IR and calculated relative Gibbs energies; main p5 explicitly compares AK,AE,Z-HK,E-HK for7a in gas and chloroform. They use ORCA B3LYP-D3(BJ)/6-311+G* with gas/CPCM chloroform models and CAM-B3LYP/6-311+G* TD absorption in chloroform (pp6–7). They relate CF3/aryl substitution to frontier orbitals and describe solvent hydrogen bonding. Main p7 prints Eg=EHOMO−ELUMO while discussing a positive gap: reproduce the actual numerical convention explicitly rather than treating that sign expression as a physical definition. The broader two-solvent species/diagnostic matrix in V1 was a benchmark addition; it is not the source protocol. Experimental solid XRD/IR evidence and solution evidence must retain their separate conditions. For the 7a proton resonance at 14.07 ppm, main PDF p14 labels the 1H NMR medium DMSO-d6 (500 MHz), whereas the SI PDF p155 spectrum acquisition panel labels SOLVENT CDCl3, TE 296.4 K and SFO1 500.1340010 MHz. Both sources show the same reported shift. The solvent provenance is unresolved; these annotations do not establish two independently measured solvent-specific observations. Do not select one label as definitive, infer solvent invariance, or treat either as an unambiguous quantitative calibration target without independent evidence. If using this resonance, retain both source annotations and assess the consequence of unresolved medium attribution. A bounded interpretation or omitting it from solvent-specific quantitative calibration is valid when justified. Resolving the publication discrepancy is not a mandatory new calculation or an agent input failure.

## existing_evidence_reuse

V1 evaluation/legacy_final_snapshot preserves the old6a reference and source evidence. That older NH-pyrazolone computation is method context, not a numerical reference for7a/8a/5g. Source main Table2 and SI7a spectra are reusable experimental observations; source computed structures/spectra remain private conditional references. No expanded independent two-solvent/reference-form calculation was completed by batch2. Main PDF14 and SI PDF155 disagree on the medium assigned to7a14.07ppm. Reuse the two annotations with this unresolved provenance, not as a calibrated single-solvent value or two independent observations.

## planned_changes

[
  "agent_input/task.md",
  "all public data to neutral systems/problem_facts/observations",
  "submission_schema.json and submission_guide.md",
  "task_info.json metadata",
  "all five active evaluator files",
  "source_scope_audit.json/md + v2_design_audit.md + reference_validation_plan",
  "paper_route and official package hashes"
]

## acceptance_checks

[
  "Three N-phenyl graphs retain composition without exocyclic stereo/winner names.",
  "Observed maxima exactly match source Table2 across the two media.",
  "No active four-form enumeration or mandatory population decomposition.",
  "Official package/hash/runtime/open_research policy and two-axis weights",
  "Public materialize exact set; no private snapshot or PR guidance in AR export",
  "AR/PR common facts/schema/scientific evaluator parity",
  "Official output_contract positive/negative fixtures; semantic verdict fixtures documented separately, not claimed as judge calibration",
  "Frozen V1 and source hashes unchanged; no new scientific calculations",
  "Public/PR/evaluator preserve main-DMSO-d6 and SI-CDCl3 separately with medium=null and no two-solvent replication claim."
]

## limitations

Source computed evidence is not a calibrated error model for these solution spectra. Missing raw instrument errors, aggregate NMR/IR ranges and media differences limit quantitative identification. Expanded alternative-reference and V2 semantic calibration/isolation remain pending. The7a14.07ppm NMR solvent is source-ambiguous (main DMSO-d6; SI CDCl3); this limits solvent-specific interpretation without blocking the optical question.

## feasibility

Source ORCA gas/CPCM DFT and TD spectra demonstrate an applicable molecular route. Gaussian/ORCA spectroscopy and Python analysis routes may support alternative claim-specific investigations. First future checks should validate graph/formula correspondence and source media, then reparse available source/legacy quantities before authorizing missing references. No new engine job was run.

## review_status

ready_for_implementation_not_coordinator_approved

## exact_legacy_artifact_inventory

evaluation/task_provenance/reference_artifact_inventory.json

## post_implementation_provenance_addendum

{
  "at": "2026-09-28T17:43:02.182024+00:00",
  "reason": "Resolve exact archived summary and available historical raw/report paths after source-bounded plan was implemented; scientific design unchanged.",
  "previous_plan_sha256": "01931ad2999b2859e100853b44cb32daef5fab5de549afaa615a818f197bad5b",
  "found_files": 24,
  "unresolved_links": 0
}

## source_correction_addendum_20260928

{
  "recorded_at": "2026-09-28T18:00:45.981235+00:00",
  "coordinator_request": "Check main PDF14 versus SI1557a NMR medium; preserve conflicting sources.",
  "main_evidence": "PDF14 compound7a characterization:1H NMR500MHz,DMSO-d6,14.07ppm",
  "SI_evidence": "PDF155 spectrum visually read:14.07ppm; SOLVENT CDCl3; TE296.4K; SFO1 500.1340010MHz",
  "prior_statement_corrected": "Exclusive CDCl3 attribution omitted the main-text DMSO-d6 label.",
  "resolution": "Source discrepancy remains unresolved; retain both, do not manufacture independent observations.",
  "previous_plan_sha256": "590ee9955aca30fb94f27a62ec14ccd3d9f04ca81f42992802485f5044136b02",
  "previous_package_hashes": {
    "autonomous_research": "e7aa7c2a9e9ab71d76e70c5fdaaf0d8971fe4d2974e4f9af22888b1fa5f70e11",
    "paper_reproduction": "d68267a410320e088f102404b6e4fe3dba3ebaaef9b54e26dec74fe73f8f5fbd"
  },
  "rendered_SI_view": "docs/upgrade_tasks_v2_review_20260928/authoring/batch2/work/review_7a_SI155.png",
  "rendered_SI_view_sha256": "73642a0c8399211faf931796d1078ba92540cd8c3401488755984ede4151c42e",
  "new_scientific_calculations_performed": false
}

